Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases

Introduction: Inclusion body myositis (IBM) is a slowly progressive degenerative inflammatory disorder affecting both proximal and distal muscles. Immunosuppressive therapies are generally ineffective in the treatment of this disorder, and most patients are resistant to steroid therapy. Some benefit...

Full description

Bibliographic Details
Main Authors: Patrick Cherin, Jean-Christophe Delain, Christophe de Jaeger, Jean-Charles Crave
Format: Article
Language:English
Published: Karger Publishers 2015-11-01
Series:Case Reports in Neurology
Subjects:
Corticosteroid
Immunoglobulin
Subcutaneous immunoglobulins
Muscle weakness
Biopsy
Inclusion body myositis
Online Access:http://www.karger.com/Article/FullText/441490

Internet

http://www.karger.com/Article/FullText/441490

Similar Items